New collaboration focuses on transforming academic research into innovative therapies for urgent medical conditions, including cancer and heart disease. The University of Southern California (USC) has ...

Driven by a passion for innovation and inclusivity, Dr Catherine Pickering, CEO of iOnctura, is on a mission to transform cancer treatment while championing diversity within the biotech industry. In ...

Watch this webinar as we investigate how challenges in AI-driven drug discovery can be overcome. In this webinar, esteemed experts will explore strategies to improve data collection, integration and ...

Avideh Nazeri, Vice President of Clinical, Medical and Regulatory for Novo Nordisk UK, reflects on her journey through the world of STEM, highlighting the resilience and determination required to ...

Driven by a passion for innovation and inclusivity, Dr Catherine Pickering, CEO of iOnctura, is on a mission to transform cancer treatment while championing diversity within the biotech industry.

The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice. Scientists at the UK Dementia Research Institute, University of ...

Small molecules are essential for developing effective medicines, but their structural complexity and material behaviour present difficulties. In this article, Chris Brown, Senior Chemist, Onyx ...

Researchers have uncovered a how INPP4B, alongside PIKfyve and TRPML-1, drives pancreatic cancer metastasis. Researchers at the University of Toronto, Toronto Metropolitan University and the Princess ...

Join us for the Bioprocessing Innovations Summit, an exclusive event focused on addressing the critical challenges and breakthroughs in the biopharmaceutical industry, specifically in the areas of ...